Overview

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Status:
Completed
Trial end date:
2014-01-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety, and tolerability of vilazodone relative to placebo in the treatment of generalized anxiety disorder (GAD).
Phase:
Phase 3
Details
Lead Sponsor:
Forest Laboratories